2-73601183-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378454.1(ALMS1):​c.11873-12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.621 in 1,613,652 control chromosomes in the GnomAD database, including 318,554 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 23968 hom., cov: 33)
Exomes 𝑓: 0.63 ( 294586 hom. )

Consequence

ALMS1
NM_001378454.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.33

Publications

18 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 2-73601183-T-C is Benign according to our data. Variant chr2-73601183-T-C is described in ClinVar as Benign. ClinVar VariationId is 383770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.11873-12T>C intron_variant Intron 18 of 22 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.11873-12T>C intron_variant Intron 18 of 22 NP_055935.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.11873-12T>C intron_variant Intron 18 of 22 1 NM_001378454.1 ENSP00000482968.1

Frequencies

GnomAD3 genomes
AF:
0.530
AC:
80501
AN:
152014
Hom.:
23970
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.231
Gnomad AMI
AF:
0.677
Gnomad AMR
AF:
0.646
Gnomad ASJ
AF:
0.667
Gnomad EAS
AF:
0.745
Gnomad SAS
AF:
0.677
Gnomad FIN
AF:
0.629
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.632
Gnomad OTH
AF:
0.567
GnomAD2 exomes
AF:
0.635
AC:
158858
AN:
250274
AF XY:
0.639
show subpopulations
Gnomad AFR exome
AF:
0.217
Gnomad AMR exome
AF:
0.722
Gnomad ASJ exome
AF:
0.683
Gnomad EAS exome
AF:
0.757
Gnomad FIN exome
AF:
0.627
Gnomad NFE exome
AF:
0.632
Gnomad OTH exome
AF:
0.650
GnomAD4 exome
AF:
0.630
AC:
921376
AN:
1461518
Hom.:
294586
Cov.:
64
AF XY:
0.632
AC XY:
459391
AN XY:
727062
show subpopulations
African (AFR)
AF:
0.210
AC:
7043
AN:
33474
American (AMR)
AF:
0.710
AC:
31751
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.682
AC:
17837
AN:
26136
East Asian (EAS)
AF:
0.734
AC:
29134
AN:
39698
South Asian (SAS)
AF:
0.667
AC:
57398
AN:
86074
European-Finnish (FIN)
AF:
0.632
AC:
33757
AN:
53414
Middle Eastern (MID)
AF:
0.617
AC:
3557
AN:
5766
European-Non Finnish (NFE)
AF:
0.632
AC:
702732
AN:
1111856
Other (OTH)
AF:
0.632
AC:
38167
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
20149
40298
60446
80595
100744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18670
37340
56010
74680
93350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.529
AC:
80512
AN:
152134
Hom.:
23968
Cov.:
33
AF XY:
0.536
AC XY:
39893
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.231
AC:
9575
AN:
41508
American (AMR)
AF:
0.646
AC:
9876
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.667
AC:
2314
AN:
3470
East Asian (EAS)
AF:
0.745
AC:
3851
AN:
5168
South Asian (SAS)
AF:
0.677
AC:
3267
AN:
4828
European-Finnish (FIN)
AF:
0.629
AC:
6656
AN:
10574
Middle Eastern (MID)
AF:
0.643
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
0.632
AC:
42968
AN:
67976
Other (OTH)
AF:
0.567
AC:
1200
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1723
3446
5169
6892
8615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
9131
Bravo
AF:
0.517
Asia WGS
AF:
0.695
AC:
2418
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Sep 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.11870-12T>C in intron 18 of ALMS1: This variant is not expected to have clinic al significance because a T>C change at this position does not diverge from the splice consensus sequence and is therefore unlikely to impact splicing. It has b een identified in 75.28% (6509/8646) of East Asian chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1320374). -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Alstrom syndrome Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
12
DANN
Benign
0.44
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1320374; hg19: chr2-73828310; COSMIC: COSV52503032; COSMIC: COSV52503032; API